Design and in silico evaluation of an mRNA vaccine against HTLV-1 using AI-driven reverse vaccinology approaches

Nadia Seifi, Navid Nezafat, Mohammad Soroosh Hajizade, Manica Negahdaripour · 2026

Read Design and in silico evaluation of an mRNA vaccine against HTLV-1 using AI-driven reverse vaccinology approaches by Nadia Seifi, Navid Nezafat, Mohammad Soroosh Hajizade, Manica Negahdaripour (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0340201.txt.

Description

Nadia Seifi and colleagues designed a possible mRNA vaccine against HTLV-1, a virus that can cause a form of leukaemia and a paralysing nerve disease. No vaccine against it exists today. Their 2026 paper is a computer-based design study: software picked the two most promising viral proteins, hunted for fragments the immune system can recognise, and stitched those fragments into a virtual vaccine.

Modelling suggested the design has suitable physical properties and docks well with an immune receptor, and simulations kept the pairing stable. The authors stress that all of this is prediction. Only laboratory and animal experiments can show whether the candidate truly protects against the virus.

Catalog record

CREATORNadia Seifi, Navid Nezafat, Mohammad Soroosh Hajizade, Manica Negahdaripour
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE62273
LICENSECC_BY
RIGHTSCC BY
SOURCEPLOS

Source: https://doi.org/10.1371/journal.pone.0340201

Browse the full library · About the Tower of Babel